The MAPKAPK2 protein levels were significantly elevated in glioma tissues compared with the para-tumor tissues and were obviously higher in GBM compared with low-grade glioma (Figures 2B–D, Table 2). This evidence concerns the gene MAPKAPK2 and glioblastoma.